Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 29-2 - June 3, 2015
- Latest edition
- Author: Joaquim Bellmunt
- Language: English
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and… Read more
Purchase options
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.
- Edition: 1
- Latest edition
- Volume: 29-2
- Published: June 3, 2015
- Language: English
JB
Joaquim Bellmunt
Affiliations and expertise
Director, Bladder Cancer Center
Dana-Farber Cancer Institute
Dana-Farber/Brigham and Women's Cancer Center
Associate Professor, Harvard Medical School